MTM LABORATORIES
DEAD

Serial Number

78668046

Owner

MTM Laboratories AG

Filing Date

Jul 12, 2005

Add to watchlist:

No watchlists yet
View on USPTO

MTM LABORATORIES Trademark

Serial Number: 78668046 • Registration: 3290364

MTM LABORATORIES is a trademark filed by MTM Laboratories AG on July 12, 2005. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

MTM Laboratories AG (7 trademarks)

Im Neuenheimer Feld 583
Heidelberg 69120 , DE

Entity Type: 03

ROCHE MTM LABORATORIES AG (7 trademarks)

IM NEUENHEIMER FELD 583
HEIDELBERG 69120 , DE

Entity Type: 03

Trademark Details

Filing Date

July 12, 2005

Registration Date

September 11, 2007

Published for Opposition

June 26, 2007

Cancellation Date

April 18, 2014

Goods & Services

Diagnostic equipment, namely, plates having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; diagnostic equipment, namely, chromatography columns and clothing for use in laboratories for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases

Pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits, comprising of medical diagnostic reagents and assays, for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations namely in-vitro and in-vivo diagnostic test kits, comprising of medical diagnostic reagents and assays, diagnostic liquid-immuno-assay kits, comprising of medical diagnostic reagents and assays, diagnostic solid-phase immuno-assay kits, comprising of medical diagnostic reagents and assays, diagnostic strip-tests, comprising of medical diagnostic reagents and assays, diagnostic dip-stick-tests, comprising of medical diagnostic reagents and assays, point of care tests, comprising of medical diagnostic reagents and assays, diagnostic lateral-flow assay kits, comprising of medical diagnostic reagents and assays, diagnostic flow-through assay kits, comprising of medical diagnostic reagents and assays, diagnostic immuno-chromatographic kits, comprising of medical diagnostic reagents and assays; diagnostic equipment namely medical diagnostic test strips for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases, cotton, wood, and plastic sticks, cotton swabs and tampons for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; therapeutic compounds and substances, namely, vaccines for prevention and treatment of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases

Diagnostic preparations, reagents and chemical test kits for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use

Medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors, detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds

Point-of-care testing machines, namely, for immunochemistry testing, medical diagnostic liquid-immuno-assay machines, medical diagnostic solid-phase immuno assay machines, medical diagnostic ELISA testing machines, medical diagnostic immuno-chromatographic machines; diagnostic equipment, namely containers for medical samples, vessels, namely, containers specially designed for storing and transporting medical samples, test tubes, namely, for medical samples and medical diagnostic testing, brushes, namely, for sampling of medical samples from body cavities and epithelia, medical syringes, needles for medical use, spatulas, namely, for medical samples and medical diagnostic testing, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases

Scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceuticals, chemistry, medical diagnostics and food technology; pharmaceutical research services, chemical research services and medical diagnostic research services for clinical, therapeutic, prophylactic and medical diagnostic applications and procedures; research and development of pharmaceutical products and substances for others; providing information on the subject of scientific research in the field of biochemistry, disease related molecular markers and molecular diagnostics; chemical, biological, molecular biology and pharmacogenomic analysis services

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 18, 2014 C8..
WITHDRAWAL OF ATTORNEY GRANTED
Mar 24, 2014 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Mar 24, 2014 WOAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 20, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 20, 2012 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 18, 2012 ASGN
REGISTERED-PRINCIPAL REGISTER
Sep 11, 2007 R.PR
PUBLISHED FOR OPPOSITION
Jun 26, 2007 PUBO
NOTICE OF PUBLICATION
Jun 6, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 23, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2007 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 17, 2007 XAEC
ASSIGNED TO LIE
Apr 17, 2007 ALIE
EXAMINERS AMENDMENT E-MAILED
Apr 16, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 16, 2007 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 21, 2007 TROA
NON-FINAL ACTION E-MAILED
Sep 21, 2006 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2006 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 7, 2006 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 4, 2006 TCCA
NON-FINAL ACTION E-MAILED
Feb 15, 2006 GNRT
NON-FINAL ACTION WRITTEN
Feb 15, 2006 CNRT
ASSIGNED TO EXAMINER
Feb 1, 2006 DOCK
NEW APPLICATION ENTERED
Jul 18, 2005 NWAP